Clinical trial
A Prospective, Observational Study in Patients With Late-Onset Pompe Disease
NCT00077662 is registered in ClinicalTrials.gov with Genzyme, a Sanofi Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Observational Study in Patients With Late-Onset Pompe Disease
- Lead sponsor
- Genzyme, a Sanofi Company
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2004
- Completion date
- January 31, 2006
- Enrollment
- 61 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.